TURMETABART

UNII:	GS07GRJ3BJ
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	TURMETABART
GSRS Full Record:	GS07GRJ3BJ i

2650574-80-2
IGHV5-51*01 (88.3%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [8.8.8] (26-33.51-58.97-104)) (1-115) -Homo sapiens IGHG1*01, G1m17,1 CH1 K120, CH3 D12, L14, 15-G1v37 h S5 (CH1 K120(212) (116-213), hinge 1-15 C5>S (218) (214-228), CH2 (229-338), CH3 D12 (354), L14 (356) (339-443), CHS K2>del (444)) (116-444)],with L-kappa light chain humanized (1'-218')[V-KAPPA (Homo sapiens IGKV3D-11*02 (87.2%)-IGKJ4*01 (100%),CDR-IMGT [10.3.9] (27'-36'.54'-56'.93'-101')) (1'-111') -Homo sapiens IGKC*01 (100%) Km3 A45.1, V101 (C-KAPPA A45.1 (157'), V101 (195')) (112'-218')];dimer (224-224'': 227-227'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, glycoform alfa
Immunoglobulin G1 [218-serine,de-445-lysine], anti-(human seizure protein 6 homolog) (human-Mus musculus monoclonal PR-1744211 γ1-chain), complex with human-Mus musculus monoclonal PR-1744211 κ-chain, dimer
PR-1744211
Turmetabart
immunoglobulin G1-kappa, anti-[Homo sapiens SEZ6 (seizure related 6 homolog)], humanized monoclonal antibody (turmetabart)
turmetabart [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

TURMETABART

Synonyms and Mappings

Resources